Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Supporters often emphasize the possibility for meaningful therapeutic benefits, principally in diseases where conventional medications have proven limited. However, this is to consider the substantial financial burden associated with CPI stem cell th